Farnesoid X Receptor Agonist Obeticholic Acid Reduces Kidney Disease in a Mouse Model of Alport Syndrome

被引：0
|
作者：
Jones, Bryce A. [1 ]
Perry, Priscilla E. [1 ]
Davidson, Shania R. [1 ,2 ]
Santiago, Isabel Lopez [1 ,3 ]
Adapa, Sharmila [1 ]
Allen, Katherine C. [1 ]
Dial, Katelyn [1 ]
Rowland, Emma [1 ]
Myakala, Komuraiah [1 ]
Wang, Xiaoxin [1 ]
Levi, Moshe
机构：
[1] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[2] Howard Univ, Coll Arts & Sci, Washington, DC 20059 USA
[3] Johns Hopkins Univ, Baltimore, MD USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-PO688
引用
收藏
页码：511 / 511
页数：1
相关论文
共 50 条
  • [41] Mouse model of X-linked Alport syndrome.
    Rheault, MN
    Kren, SM
    Thielen, BK
    Mesa, HA
    Crosson, JT
    Kashtan, CE
    Segal, Y
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 26A - 26A
  • [42] Correction: Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand
    Junhui Yu
    Kui Yang
    Jianbao Zheng
    Wei Zhao
    Xuejun Sun
    Cancer Gene Therapy, 2022, 29 : 871 - 872
  • [43] The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury
    Ferrigno, Andrea
    Di Pasqua, Laura Giuseppina
    Berardo, Clarissa
    Siciliano, Veronica
    Rizzo, Vittoria
    Adorini, Luciano
    Richelmi, Plinio
    Vairetti, Mariapia
    PLOS ONE, 2018, 13 (01):
  • [44] Farnesoid X Receptor Agonist Treatment Alters Bile Acid Metabolism but Exacerbates Liver Damage in a Piglet Model of Short-Bowel Syndrome
    Pereira-Fantini, Prue M.
    Lapthorne, Susan
    Gahan, Cormac G. M.
    Joyce, Susan A.
    Charles, Jenny
    Fuller, Peter J.
    Bines, Julie E.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2017, 4 (01): : 65 - 74
  • [45] LONG-TERM (LT) THERAPY OF A FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) MAINTAINS BIOCHEMICAL RESPONSE IN PRIMARY BILIARY CIRRHOSIS (PBC)
    Hirschfield, G.
    Kowdley, K.
    Mason, A.
    Luketic, V.
    Gordon, S.
    Vincent, C.
    Mayo, M.
    Pares, A.
    Chapman, R.
    Lindor, K.
    Esguerra, M.
    Eliot, L.
    Shapiro, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S372 - S372
  • [46] FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
    Len Verbeke
    Inge Mannaerts
    Robert Schierwagen
    Olivier Govaere
    Sabine Klein
    Ingrid Vander Elst
    Petra Windmolders
    Ricard Farre
    Mathias Wenes
    Massimiliano Mazzone
    Frederik Nevens
    Leo A. van Grunsven
    Jonel Trebicka
    Wim Laleman
    Scientific Reports, 6
  • [47] FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
    Verbeke, Len
    Mannaerts, Inge
    Schierwagen, Robert
    Govaere, Olivier
    Klein, Sabine
    Elst, Ingrid Vander
    Windmolders, Petra
    Farre, Ricard
    Wenes, Mathias
    Mazzone, Massimiliano
    Nevens, Frederik
    van Grunsven, Leo A.
    Trebicka, Jonel
    Laleman, Wim
    SCIENTIFIC REPORTS, 2016, 6
  • [48] THE FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) INCREASES PLASMA FGF-19 CONCENTRATIONS AND DECREASES BILE ACID SYNTHESIS IN PRIMARY BILIARY CIRRHOSIS (PBC)
    Marschall, H. -U.
    Luketic, V.
    Lovgren-Sandblom, A.
    Benthin, L.
    Kowdley, K.
    Hirschfield, G.
    Mason, A.
    Lindor, K.
    Gordon, S.
    Vincent, C.
    Chapman, R.
    Mayo, M.
    Burroughs, A.
    Pares, A.
    Jones, D.
    Schramm, C.
    Eliot, L.
    Hofmann, A. F.
    Shapiro, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S377 - S377
  • [49] The Farnesoid X Receptor (FXR) Agonist Edp-305 Reduces Ascites and Hepatocellular Carcinoma Development in a Rat Model of Cirrhosis
    Ghoshal, Sarani
    Arora, Gunisha
    Masia, Ricard
    Sojoodi, Mozhdeh
    Ferreira, Diego Dos Santos
    Caravan, Peter
    Li, Yang
    Wang, Guoqiang
    Or, Yat Sun
    Jiang, Lijuan
    Tanabe, Kenneth K.
    Fuchs, Bryan C.
    HEPATOLOGY, 2018, 68 : 1251A - 1252A
  • [50] An Agonist of Liver X Receptor Slows Valvular Disease in a Hypercholesterolemia Mouse Model
    Wang, Haimei
    Goland, Sorel
    Burton, Kevin
    Czer, Lawrence S. C.
    Schwarz, Ernst R.
    Trento, Alfredo
    JOURNAL OF HEART VALVE DISEASE, 2010, 19 (05): : 653 - 664
12345